Therefore, investigation of CD4+ helper T cell subsets in the IBD mLNs, which are not easily accessible for research use, has clear implications in further understanding disease pathogenesis and thus, open avenues for personalized medicine. The gene discussed is CD4; the disease is inflammatory bowel disease.